Peptides for Longevity & Anti-Aging: What’s Actually Studied

“Longevity” peptides are a loose group of lab-made compounds, such as Epitalon, MOTS-c and GHK-Cu, that researchers are studying for possible effects on aging inside your cells. That research covers energy production in your mitochondria (the tiny structures inside cells that turn food into usable energy), skin and tissue repair, and other processes tied to how cells wear out over time.

None of these compounds is FDA-approved to slow or treat aging, and most of the evidence is still early. So far it comes mostly from animal studies, and the human data is well behind the hype.

This page covers what has actually been studied, what hasn’t, how each compound’s legal status looks right now, and who really sells each one.

What “longevity peptides” actually means

A peptide is a short chain of amino acids, the same building blocks that make up proteins, only much shorter. Your body makes thousands of them naturally, and some approved medicines are peptides too.

“Longevity peptides” isn’t a medical category. It’s a marketing and research label for peptides that scientists have linked, usually in lab or animal studies, to processes that change as you age.

Here’s what the label doesn’t mean. No peptide has been shown to reverse aging or extend human lifespan. “Studied for longevity” means someone ran an experiment, often in mice or in cells growing in a dish. It doesn’t mean the peptide works in people.

One more note: NAD+ gets grouped into this category constantly, but it isn’t a peptide at all. It’s a coenzyme, meaning a helper molecule your cells need to run many chemical reactions, including making energy. It’s included here because that’s where people look for it.

The peptides most associated with this category

Each card below gives the short answer and links to that compound’s full Peptide Encyclopedia entry.

Epitalon

Epitalon is a lab-made copy of a tiny four-amino-acid peptide. It’s best known for animal studies on telomerase, an enzyme that helps protect telomeres, the protective caps on the ends of your chromosomes that shorten as cells divide.

Epitalon is under review for potential compounding-pharmacy eligibility, as of September 2026. It is not FDA-approved for any use. In practice, it’s sold mainly by “research use only” websites that sell directly to consumers. These sites require no prescription, provide no medical oversight and offer no guarantee of purity or dose. Full entry: Epitalon →

MOTS-c

MOTS-c is a peptide your body makes naturally from instructions stored in your mitochondria rather than in the main part of your DNA. Mouse studies have looked at its role in how the body handles blood sugar and responds to exercise. MOTS-c is under review for potential compounding-pharmacy eligibility, as of September 2026. It is not FDA-approved for any use. Like Epitalon, it’s sold mainly through “research use only” websites with no prescription, no medical supervision and no purity or dosing guarantee. Full entry: MOTS-c →

GHK-Cu

GHK-Cu is a small peptide bound to copper that occurs naturally in your blood. It’s studied mainly for skin and wound repair. It comes in two different forms, and they’re regulated differently:

• Topical GHK-Cu is a cosmetic ingredient in serums and creams. You can buy it openly without a prescription.
• Injectable GHK-Cu is sold as a “research use only” product, and it is not approved for human use as of September 2026.

A skincare product containing GHK-Cu is not the same product as the injectable version, and the research on one doesn’t carry over to the other. Full entry: GHK-Cu →

NAD+

NAD+ is the coenzyme mentioned above (a helper molecule, not a peptide). Studies suggest its levels fall with age in some tissues. NAD+ is classified as research-use-only and not approved for human use, as of September 2026. NAD+ shows up in two separate channels. The first is IV infusions at longevity clinics and medspas, where staff give it through a drip in your arm. The second is “research use only” powder sold online with no oversight. Full entry: NAD+ →

SS-31 (elamipretide)

SS-31 is the research name for elamipretide, a peptide designed to attach to the inner membrane of the mitochondria. SS-31 is the one compound in this category with an FDA approval. Elamipretide is FDA-approved, under the brand name Forzinity, for one use only: improving muscle strength in people with Barth syndrome, a rare inherited disease that affects the mitochondria. That’s current as of September 2026 (FDA prescribing information). The approval is an “accelerated approval,” which means the FDA approved it based on an early sign of benefit and still requires further confirmation. It is not approved for aging or longevity.

The approved drug is filled by prescription through a specialty pharmacy. The “SS-31” sold on “research use only” websites is a different product. It has no FDA manufacturing oversight, no purity guarantee and no prescriber involved. Full entry: SS-31 →

Humanin

Humanin is a small peptide your body makes naturally, and like MOTS-c, it’s made from instructions in your mitochondria. Lab and animal studies have looked at whether it helps protect cells under stress. Humanin is classified as research-use-only and not approved for human use, as of September 2026. It’s sold mainly by “research use only” websites that require no prescription, provide no medical supervision and don’t guarantee what’s in the vial. Full entry: Humanin →

What the evidence actually shows, compound by compound

“Preclinical” means research done in cells or animals before any testing in people. That’s where most of this category still sits.

• Epitalon: Most of the research is in animals and cells, plus some small human studies. Much of that work comes from one research group in Russia and hasn’t been widely repeated by independent teams.
• MOTS-c: The evidence is mostly mouse studies on metabolism and exercise capacity. Human data is limited to measurements of how much MOTS-c people naturally have, plus early-stage testing of a modified version.
• GHK-Cu: There are small human studies of topical skincare use, but the evidence for the injectable form is mostly lab and animal research. The skin data doesn’t tell you anything about injections.
• NAD+: NAD+ has a long history of use in clinics, but that isn’t the same as strong evidence. Controlled trials of IV NAD+ are small. Most human research has tested precursors, meaning supplements your body converts into NAD+, and results on real health outcomes have been mixed.
• SS-31: SS-31 has the most rigorous human data in this group. It went through controlled human trials that led to the Barth syndrome approval, and it’s in a late-stage trial for an eye disease. None of that research tested it as an anti-aging treatment.
• Humanin: The evidence is mostly cell and animal studies, plus observational human research linking natural humanin levels to age. Observational means the researchers measured levels without giving anyone humanin. No controlled human trials of humanin as a treatment were identified.

Current legal and regulatory status

Status changes fast in this category, so the live picture is on our Regulatory Tracker, which we check every week. Here’s the summary as of September 2026:

• SS-31 (elamipretide): FDA-approved for improving muscle strength in Barth syndrome only (accelerated approval). It is not approved for aging.
• Epitalon and MOTS-c: Both are under review for potential compounding-pharmacy eligibility. A compounding pharmacy is a licensed pharmacy that mixes medications for individual patients with a prescription. In July 2026, the FDA’s Pharmacy Compounding Advisory Committee (PCAC), an outside panel that advises the agency, recommended adding both to the list of ingredients these pharmacies may use. That vote is non-binding. The FDA has not issued a final decision, and the FDA’s list currently shows both as “nomination withdrawn.” Neither is approved.
• GHK-Cu: It’s a legal cosmetic ingredient in topical skincare. The injectable form is classified as research-use-only and not approved for human use.
• NAD+ and Humanin: Both are classified as research-use-only and not approved for human use. Our Tracker has found no movement toward compounding eligibility for either.

See the live Regulatory Tracker →

How these are actually sold, and what that means

Four different channels sell compounds in this category, and each one guarantees very different things:

• Prescription through a licensed pharmacy: This currently applies only to elamipretide (Forzinity) for Barth syndrome. You get FDA manufacturing oversight, a prescriber and a licensed pharmacist who is accountable for what’s dispensed.
• Compounding pharmacy: Compounding pharmacies are licensed and inspected by state boards, and they need a prescription. They are not the same as FDA-approved manufacturing. None of the compounds on this page is confirmed eligible for compounding yet.
• Longevity clinics and medspas: This is mainly where NAD+ IV drips come from. You get some medical staff involvement, but the product itself isn’t FDA-approved for these uses, and oversight varies widely from clinic to clinic.
• “Research use only” websites: These are the main source for injectable Epitalon, MOTS-c, SS-31, Humanin and GHK-Cu. They require no prescription and provide no medical supervision. There’s no FDA oversight of manufacturing, no guaranteed purity or dose, and you have no legal protection if the product isn’t what the label says. The “research use only” label also means the product isn’t sold for human use.

Being able to buy something online tells you nothing about whether it’s safe, effective or legal to use. That’s why the channel matters more than the product page.

Related categories

Longevity and metabolic health overlap a lot. MOTS-c, for example, is studied partly for its effects on blood sugar. If that’s what brought you here, the next hub to read is:

Weight Loss & GLP-1 Peptides → — Semaglutide, tirzepatide and the peptides behind the biggest shift in weight-loss medicine in a decade.

FAQs about longevity peptides